FRANKFURT, Dec 14 (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly (LLY.N), opens new tab and Regeneron (REGN.O), opens new tab lose most of their effectiveness ...

Blood collected from survivors of COVID-19 has been used to identify antibodies against the disease, which have been turned into experimental drugs to fight it. But it’s not an easy process. So back ...

ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 GeneSystems, Inc., today announced that it has received its first allotment of the new Elecsys Anti-SARS-CoV-2 S lab-based blood test that quantitatively ...

With the world watching for whether the current crop of COVID-19 vaccines works, LabCorp has launched a new coronavirus antibody test designed to to determine just that. The company's Cov2Quant test ...

HONOLULU (KITV4) -- A simple blood test can indicate the difference between someone who has recovered from COVID-19 and someone who continues to produce antibodies after getting vaccinated. Tests show ...

The test measures immunoglobulin G antibodies, which indicate past exposure or vaccination to viruses like measles.

"We feel this pressure because we want to help people." Antibody tests, which reveal whether someone has been infected with the novel coronavirus, have been touted as key to reopening the economy and ...

FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron ...